Replies to post #32529 on Endonovo Therapeutics Inc (ENDV)

[srinsocal]

I could give the 'bad management' theory more weight if it were not for the fact that Sofpulse is into its third ownership.

Started out as Ivivi Sofpulse with an FDA Clearance in 2008, no traction.

Went to Rio Grande Sofpulse, no traction.

Now its Endonovo Sofpulse for the last 4 years and no traction.

Did all 3 owners have 'bad management'?